Cointime

Ichosia Biotechnology

company

About

Ichosia Biotechnology develops derived red blood cells in order to capitalize on natural genetic processes.

  • 1 - 10

Highlights

Total Funding Amount
$50K
Funding Rounds
1
Investors
1
Investments
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$50K
Industries
Biotechnology,Health Care,Medical Device
Founded date
Sep 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

Ichosia Biotechnology develops derived red blood cells in order to capitalize on natural genetic processes. The company was founded in 2019 and is headquartered in Worcester, Massachusetts, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$50K
Ichosia Biotechnology has raised a total of $50K in funding over 2 rounds. Their latest funding was raised on Jul 15, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 15, 2020 Grant $50K 1 National Science Foundation — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Ichosia Biotechnology has made 1 investments. Their most recent investment was on Oct 31, 2022, when Februar raised €1.50M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 31, 2022 Februar
Pre-seed €1.50M Bitcoin —

Investors

Number of Lead Investors
Number of Investors
1
1
Ichosia Biotechnology is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Cointime
Содержание
компания